Comparative efficacy and acceptability of new-generation antidepressants. Synthesis meta-analysis "Cipriani";Efficacité et acceptabilité des antidépresseurs de nouvelle génération. Synthèse de la méta-analyse « Cipriani »

Encephale

Volumn 35, Issue 5, 2009, Pages 499-504

  Gaillard, R ^a  

^a CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Antidepressant; Meta analysis; Unipolar depression

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; MILNACIPRAN; MIRTAZAPINE; PAROXETINE; REBOXETINE; SERTRALINE; VENLAFAXINE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER, MAJOR; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 71149110332     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.encep.2009.07.003     Document Type: Short Survey

References (9)

1. Bekelman J.E., Li Y., and Gross C.P. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. Jama 289 4 (2003) 454-465
2. Cipriani A., et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373 9665 (2009) 746-758
3. Gartlehner G, Hansen RA, Thieda P. Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression. Agency Health Care Res Qual 2007;http://www.effectivehealthcare.ahrq.gov/reports/final.cfm.
4. Hansen R.A., et al. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 143 6 (2005) 415-426
5. Kirsch I., et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5 2 (2008) 45
6. Lu G., and Ades A.E. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 23 20 (2004) 3105-3124
7. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 21 16 (2002) 2313-2324
8. Turner E.H., et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 358 3 (2008) 252-260
9. Walsh B.T., et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287 14 (2002) 1840-1847